

About Axonlogs
We speak both languages — the journal's and the clinic's
Axonlogs exists in the space between a published finding and a daily decision. We read the research so practitioners don't have to translate it themselves.
Why THIS PAGE exist
Knowledge should belong to everyone.
Neurodegenerative research is published in a language built for other researchers — dense, hedged, and locked behind methodology most people never trained to read. But a diagnosis doesn't wait for a translator. Axonlogs was built to be that translator: reading the primary literature as it's published, and writing it back out as something anyone affected can actually use.
How a signal travels
From finding to protocol
01
02
03
04
Source
Appraisal
Synthesis
Protocol
We track peer-reviewed publications across the major neurodegenerative journals as they release.
Each finding is weighed against study size, replication, and existing consensus before it's trusted.
What survives appraisal is rewritten in plain language, stripped of jargon, without losing precision.
The result is a dated, sourced, practical recommendation — built to be checked, not just believed.
Review board
Every article is reviewed and verified by our team
REVIEWER 1
REVIEWER 2
REVIEWER 3
Jeremy Huwae
Bachelor of Psychology and Neuropsychology student
TBA
TBA
TBA
TBA
Axonlogs
Translating neurodegenerative research into accessable knowledge
Library
Home
Library
Standards
Contact
Connect
editorial@axonlogs.com
Based in Boston, MA
Updated weekly with peer-reviewed research
© 2026 Axonlogs-Independent clinical translation for families and researchers.
EVIDENCE-BASED DAILY PROTOCOLS